NO20092019L - Behandling av gjennomtrengende utviklingsforstyrrelser - Google Patents
Behandling av gjennomtrengende utviklingsforstyrrelserInfo
- Publication number
- NO20092019L NO20092019L NO20092019A NO20092019A NO20092019L NO 20092019 L NO20092019 L NO 20092019L NO 20092019 A NO20092019 A NO 20092019A NO 20092019 A NO20092019 A NO 20092019A NO 20092019 L NO20092019 L NO 20092019L
- Authority
- NO
- Norway
- Prior art keywords
- disorder
- developmental disorders
- pervasive developmental
- treatment
- pdds
- Prior art date
Links
- 208000029560 autism spectrum disease Diseases 0.000 title abstract 7
- 208000012202 Pervasive developmental disease Diseases 0.000 title abstract 5
- 208000036640 Asperger disease Diseases 0.000 abstract 2
- 201000006062 Asperger syndrome Diseases 0.000 abstract 2
- 208000020706 Autistic disease Diseases 0.000 abstract 2
- 208000006289 Rett Syndrome Diseases 0.000 abstract 2
- 208000036353 Rett disease Diseases 0.000 abstract 2
- 201000007197 atypical autism Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86359506P | 2006-10-31 | 2006-10-31 | |
| PCT/US2007/081365 WO2008054984A1 (en) | 2006-10-31 | 2007-10-15 | Treatment of pervasive developmental disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092019L true NO20092019L (no) | 2009-06-23 |
Family
ID=39145417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092019A NO20092019L (no) | 2006-10-31 | 2009-05-25 | Behandling av gjennomtrengende utviklingsforstyrrelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080103199A1 (pt) |
| EP (1) | EP2089011A1 (pt) |
| JP (1) | JP2010508354A (pt) |
| KR (1) | KR20090080105A (pt) |
| CN (1) | CN101568333A (pt) |
| AU (1) | AU2007313911A1 (pt) |
| BR (1) | BRPI0718323A2 (pt) |
| CA (1) | CA2667909A1 (pt) |
| CO (1) | CO6180427A2 (pt) |
| EA (1) | EA200970435A1 (pt) |
| GT (1) | GT200900112A (pt) |
| IL (1) | IL198488A0 (pt) |
| MX (1) | MX2009004798A (pt) |
| NI (1) | NI200900074A (pt) |
| NO (1) | NO20092019L (pt) |
| WO (1) | WO2008054984A1 (pt) |
| ZA (1) | ZA200903772B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
| US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
| WO2010020585A1 (en) * | 2008-08-18 | 2010-02-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin reuptake inhibitors for the treatment of rett syndrome |
| EP2601609B1 (en) | 2010-08-02 | 2017-05-17 | Population Bio, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| WO2013054200A2 (en) | 2011-10-10 | 2013-04-18 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| EP2773779B1 (en) | 2011-11-04 | 2020-10-14 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
| US10407724B2 (en) | 2012-02-09 | 2019-09-10 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| US9517254B2 (en) * | 2012-08-06 | 2016-12-13 | S1 Biopharma, Inc. | Treatment regimens |
| DK2895621T3 (da) | 2012-09-14 | 2020-11-30 | Population Bio Inc | Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande |
| WO2014052855A1 (en) | 2012-09-27 | 2014-04-03 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
| WO2014142547A1 (en) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for neuroprotection comprising the same |
| CA2996445A1 (en) | 2014-09-05 | 2016-03-10 | Eli Hatchwell | Methods and compositions for inhibiting and treating neurological conditions |
| CN110290788A (zh) * | 2016-12-14 | 2019-09-27 | 爱思开生物制药株式会社 | 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途 |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| FI4177356T3 (fi) | 2018-08-08 | 2024-08-07 | Pml Screening Llc | Menetelmiä virustaudin kehittymisriskin arviointiin geenitestillä |
| KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS50676B (sr) * | 2001-02-27 | 2010-06-30 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja |
| DK1401424T3 (da) * | 2001-02-27 | 2007-02-26 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser |
| DE60220043T2 (de) * | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen |
| HUP0303243A3 (en) * | 2001-02-27 | 2012-07-30 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing and treating bipolar disorder |
| PT1809273E (pt) * | 2004-09-16 | 2010-05-10 | Janssen Pharmaceutica Nv | Utililização de 2-fenil-1,2-etanodiol-(di)carbamatos para tratamento de epileptogénese |
-
2007
- 2007-10-15 JP JP2009535384A patent/JP2010508354A/ja not_active Withdrawn
- 2007-10-15 MX MX2009004798A patent/MX2009004798A/es not_active Application Discontinuation
- 2007-10-15 EP EP07844287A patent/EP2089011A1/en not_active Withdrawn
- 2007-10-15 EA EA200970435A patent/EA200970435A1/ru unknown
- 2007-10-15 CA CA002667909A patent/CA2667909A1/en not_active Abandoned
- 2007-10-15 CN CNA2007800482055A patent/CN101568333A/zh active Pending
- 2007-10-15 AU AU2007313911A patent/AU2007313911A1/en not_active Abandoned
- 2007-10-15 US US11/872,177 patent/US20080103199A1/en not_active Abandoned
- 2007-10-15 WO PCT/US2007/081365 patent/WO2008054984A1/en not_active Ceased
- 2007-10-15 KR KR1020097011061A patent/KR20090080105A/ko not_active Withdrawn
- 2007-10-15 BR BRPI0718323-2A patent/BRPI0718323A2/pt not_active Application Discontinuation
-
2009
- 2009-04-30 NI NI200900074A patent/NI200900074A/es unknown
- 2009-04-30 GT GT200900112A patent/GT200900112A/es unknown
- 2009-04-30 IL IL198488A patent/IL198488A0/en unknown
- 2009-05-25 NO NO20092019A patent/NO20092019L/no not_active Application Discontinuation
- 2009-05-29 ZA ZA200903772A patent/ZA200903772B/xx unknown
- 2009-06-01 CO CO09056106A patent/CO6180427A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010508354A (ja) | 2010-03-18 |
| US20080103199A1 (en) | 2008-05-01 |
| ZA200903772B (en) | 2010-08-25 |
| GT200900112A (es) | 2010-05-18 |
| IL198488A0 (en) | 2010-02-17 |
| WO2008054984A1 (en) | 2008-05-08 |
| MX2009004798A (es) | 2009-08-12 |
| EA200970435A1 (ru) | 2009-10-30 |
| CO6180427A2 (es) | 2010-07-19 |
| BRPI0718323A2 (pt) | 2013-11-26 |
| KR20090080105A (ko) | 2009-07-23 |
| NI200900074A (es) | 2010-02-01 |
| AU2007313911A1 (en) | 2008-05-08 |
| EP2089011A1 (en) | 2009-08-19 |
| CN101568333A (zh) | 2009-10-28 |
| CA2667909A1 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009004798A (es) | Tratamiento de los trastornos generalizados del desarrollo. | |
| EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
| EA201391786A1 (ru) | Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
| EA201391670A1 (ru) | 1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
| BR112013031510A2 (pt) | [1,3]oxazinas | |
| NO20084931L (no) | Farmasoytiske sammensetninger | |
| EA201391752A1 (ru) | Спиро-[1,3]-оксазины и спиро-[1,4]-оксазепины в качестве ингибиторов bace1 и/или bace2 | |
| EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201200054A1 (ru) | Лечение токотриенолами или экстрактами, богатыми токотриенолами, первазивных расстройств развития | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| DOP2006000170A (es) | Nuevos derivados de espirocromanona | |
| EA201200406A1 (ru) | Соединения и композиции, которые являются модуляторами активности tlr | |
| EA200800564A1 (ru) | Производные ксантина как селективные агонисты нм74а | |
| EA200900983A1 (ru) | Соединения и композиции в качестве ингибиторов киназы | |
| EA201692506A3 (ru) | Ингибиторы репликации вирусов гриппа | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| ECSP067043A (es) | Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis | |
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
| EA201290517A1 (ru) | Гетероароматические арилтриазольные производные в качестве ингибиторов фермента pde10a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |